2025 International Congress Archives - Page 158 of 181

The discrepancy between self-reported hyposmia and objective assessment by Sniffin’ sticks in high risk of synucleinopathies and healthy controls.

J. Sringean, S. Phumphid, C. Anan, J. Meesri, P. Rattanajun, S. Wehhinhiran, A. Chantadunga, T. Sanengmanee, R. Bhidayasiri (Bangkok, Thailand)
The Dutch Yips Study- part V: The VIdeo Panel (VIP)-Study

E. van Wensen, B. Nijenhuis, E. van Leeuwen, J. Zwerver, M. de Koning-Tijssen, B. Vande Warrenburg, T. Schermer (Apeldoorn, Netherlands)
The Dystonia Coalition: Natural History & Biorepository Projects Update

J. Perlmutter (St Louis, USA)
The East London Parkinson Disease Project: cultural fairness of common cognitive screening tests

A. Zirra, KC. Dey, E. Camboe, E. Bhadra, T. Haque, S. Waters, DA. Gallagher, C. Budu, B. Huxford, C. Simonet, C. Edwards, S. Ali, R. Weil, N. Mukadam, AJ. Lees, T. Boyle, MT. Perinan, CR. Marshall, AJ. Noyce (London, United Kingdom)
The East London Parkinson Disease Project: Higher Immune Activation found in Patients with Parkinson’s Disease Dementia from a Diverse Population

A. Zirra, KC. Dey, E. Camboe, E. Bhadra, B. Huxford, R. Laban, N. Donkor, F. Nice, S. Valle Thomas, A. Gaspariunas, L. Mitchell, DA. Gallagher, C. Budu, C. Simonet, T. Boyle, AJ. Lees, D. Yadin, J. Dias, O. Cavlan, CR. Marshall, MT. Perinan, AJ. Noyce (London, United Kingdom)
The Effect of Body Position on Cortical and Peripheral Neurophysiology of Adductor-type Laryngeal Dystonia: A Pilot Study

J. Pierce, R. Gillam, B. Kirwan, A. Dorval, A. Hancock, A. Stark, D. Legler, H. da Silva, M. Smith, K. Simonyan, J. Barkmeier-Kraemer (Salt Lake City, USA)
The effect of continuous subcutaneous foslevodopa/foscarbidopa infusion on sleep in Parkinson’s disease: three case reports

H. Sakuramoto, H. Fujita, K. Suzuki (Shimotuga Mibu, Japan)
The Effect of Foslevodopa/Foscarbidopa Treatment on Nonmotor Symptom Burden in Advanced Parkinson’s Disease

I. Malaty, P. Odin, D. Kern, L. Bergmann, M. Shah, R. Gupta, A. Antonini, K. Chaudhuri (Gainesvile, USA)
The Effect of Melatonin on Sleep Quality and Daytime Sleepiness in Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

A. Zrineh, R. Akwan, MM. Elsharkawy, B. Douden, W. Sleibi, M. Eldesouki (Al-Quds, State of Palestine)
The effect of trial numbers on prism adaptation in Parkinson’s disease

K. Taneda, T. Shimizu, N. Tokuda, S. Moriyasu, T. Nakamura, T. Murakami, Y. Ugawa, R. Hanajima (Yonago, Japan)